Share：
Share this content in WeChat
X
[Chinese][PDF]80278
• Technical Article •
Proton magnetic resonance spectroscopy of the breast
ZHANG Wei-jun  FU Cai-xia 

DOI:10.3969/j.issn.1674-8034.2011.05.010.


[Abstract] Contrast-enhanced MRI has gained acceptance as an important breast imaging modality. However, it does not always provide a definitive pathology. Initial studies where in vivo proton MR spectroscopy has been added as an adjunct to dynamic contrast-enhanced MR imaging of the breast have shown promising results and a growing number of research groups are incorporating the technique into their breast MR protocols. The aim of this article is to illustrate the expected examination results and outline some of the pitfalls associated with undertaking a breast MRS examination.
[Keywords] Magnetic resonance imaging；Magnetic resonance spectroscopy；Breast

ZHANG Wei-jun SW Dept., Siemens Mindit Magnetic Resonance Ltd., Shenzhen 518057, China

FU Cai-xia SW Dept., Siemens Mindit Magnetic Resonance Ltd., Shenzhen 518057, China

*Correspondence to: Zhang WJ, E-mail: weijun.zhang@siemens.com

Conflicts of interest   None.

致谢： 感谢西门子MAGNETOM Flash杂志以及原文作者Peter Stanwell博士等的大力支持。
Received  2011-06-05
Accepted  2011-07-08
DOI: 10.3969/j.issn.1674-8034.2011.05.010
DOI:10.3969/j.issn.1674-8034.2011.05.010.

[1]
Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin, 2007, 57(2): 75-89.
[2]
Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med, 2007, 356(13): 1295-1303.
[3]
Stanwell P, Gluch L, Clark D, et al. Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5T. Eur Radiol, 2005, 15(5): 1037-1043.
[4]
Bolan PJ, Meisamy S, Baker EH, et al. In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med, 2003, 50(6): 1134-1143.
[5]
Meisamy S, Bolan PJ, Baker EH, et al. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo 1H MR spectroscopy - A pilot study at 4 T. Radiology, 2004, 233(2): 424-431.
[6]
Baek HM, Chen JH, Yu HJ, et al. Detection of choline signal in human breast lesions with chemical-shift imaging. J Magn Reson Imaging, 2008, 27(5): 1114-1121.
[7]
Stanwell P, Mountford C. In vivo proton MR spectroscopy of the breast. Radiographicsm, 2007, 27 (Suppl 1): S253-S266.
[8]
Bolan PJ, DelaBarre L, Baker EH, et al. Eliminating spurious lipid sidebands in 1H MRS of breast lesions. Magn Reson Med, 2002, 48(2): 215-222.
[9]
Kvistad KA, Bakken IJ, Gribbestad IS, et al. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J Magn Reson Imaging, 1999, 10(2): 159-164.
[10]
Joe BN, Chen VY, Salibi N, et al. Evaluation of 1H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration. Invest Radiol, 2005, 40(7): 405-411.
[11]
Lenkinski RE, Wang X, Elian M, et al. Interaction of gadolinium-based MR contrast agents with choline: implications for MR spectroscopy (MRS) of the breast. Magn Reson Med, 2009, 61(6): 1286-1292.
[12]
Bolan PJ, Henry PG, Baker EH, et al. Measurement and correction of respiration-induced B0 variations in breast 1H MRS at 4 Tesla. Magn Reson Med, 2004, 52(6): 1239-1245.
[13]
Baek HM, Chen JH, Nie K, et al. Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer by Using MR Imaging and Quantitative 1H MR Spectroscopy. Radiology, 251(3): 653-662.

PREV MR diffusion weighted imaging for pancreatic carcinoma
NEXT Problems in manuscripts of clinical studies of functional magnetic resonance imaging
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn